Literature DB >> 33506301

Paraneoplastic neuromyelitis optica spectrum disorders: a case series.

Eleonora Virgilio1, Domizia Vecchio2,3, Marco Vercellino4, Paola Naldi2, Fabiana Tesser5, Roberto Cantello2, Paola Cavalla4, Cristoforo Comi3,5.   

Abstract

Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic autoimmune diseases, presenting with optic neuritis (ON), longitudinally extensive transverse myelitis (LETM), and brainstem syndromes and a prevalence range between 0.5 and 4/100,000. Only 3% to 25% of NMOSD have been described as a paraneoplastic (PN) syndrome (PNNMOSD). Both idiopathic NMOSD (INMOSD) and PNNMOSD cases mostly affect females, but PNNMOSD usually presents with a spinal cord or brainstem involvement in elderly patients. Few cases of both malignancies (for the majority breast or lung cancer) and benign tumors (monoclonal gammopathy) were previously reported. Currently, there is no consensus on treatment approach for PNNMOSD (only surgical removal or surgery combined with chronic immunosuppression). Here, we present a series of three newly diagnosed PNNMOSD cases, who differ from each other for demographic and clinical features, tumor association, long-term treatment, and outcome. We propose that a PN etiology should be considered always whenever a new diagnosis of NMOSD is made, not only in patients over 50 years old or in spinal cord/brainstem lesions presentations. Our findings add to existing evidence and raise awareness on PNNMOSD. We enhance the importance for the clinicians of recognizing tumor symptoms and signs whenever a NMOSD is newly diagnosed.

Entities:  

Keywords:  Aquaporin-4; Neuromyelitis optica spectrum disorders; Optic neuritis; Paraneoplastic syndrome; Transverse myelitis

Mesh:

Substances:

Year:  2021        PMID: 33506301     DOI: 10.1007/s10072-021-05055-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma.

Authors:  Lisa M Deuel; Marjorie E Bunch
Journal:  J Neuroimmunol       Date:  2018-01-03       Impact factor: 3.478

2.  Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma.

Authors:  Kyle Blackburn; Cynthia Wang; Benjamin Greenberg
Journal:  J Neuroimmunol       Date:  2019-10-30       Impact factor: 3.478

Review 3.  Diagnostics of paraneoplastic neurological syndromes.

Authors:  Marco Zoccarato; Matteo Gastaldi; Luigi Zuliani; Tiziana Biagioli; Marco Brogi; Gaetano Bernardi; Elena Corsini; Elena Bazzigaluppi; Raffaella Fazio; Claudia Giannotta; Eduardo Nobile-Orazio; Gianna Costa; Raffaele Iorio; Amelia Evoli; Sara Mariotto; Sergio Ferrari; Elisabetta Galloni; Valentina De Riva; Elisabetta Zardini; Diego Franciotta; Bruno Giometto
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

4.  Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.

Authors:  Philippe Beauchemin; Raffaele Iorio; Anthony L Traboulsee; Thalia Field; Anna V Tinker; Robert L Carruthers
Journal:  Mult Scler Relat Disord       Date:  2017-12-23       Impact factor: 4.339

5.  Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer.

Authors:  Weijing Liao; Cheng Li; Yulan Tang; Fan Huang; Huimin Kuang; Shuolin Liang; Yi Yang
Journal:  Mult Scler Relat Disord       Date:  2019-02-08       Impact factor: 4.339

6.  Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability.

Authors:  Carolina Candeias da Silva; Denis Bernardi Bichuetti; Sonia Maria Cesar de Azevedo Silva; Henrique Ballalai Ferraz; Enedina Maria Lobato de Oliveira; Vanderci Borges
Journal:  Parkinsonism Relat Disord       Date:  2018-03-03       Impact factor: 4.891

Review 7.  Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Authors:  R A Kyle; B G M Durie; S V Rajkumar; O Landgren; J Blade; G Merlini; N Kröger; H Einsele; D H Vesole; M Dimopoulos; J San Miguel; H Avet-Loiseau; R Hajek; W M Chen; K C Anderson; H Ludwig; P Sonneveld; S Pavlovsky; A Palumbo; P G Richardson; B Barlogie; P Greipp; R Vescio; I Turesson; J Westin; M Boccadoro
Journal:  Leukemia       Date:  2010-04-22       Impact factor: 11.528

Review 8.  Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.

Authors:  Gang Cai; Dian He; Lan Chu; Qingqing Dai; Zhu Xu; Yifan Zhang
Journal:  Int J Neurosci       Date:  2015-08-18       Impact factor: 2.292

9.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

10.  Aquaporin-4 autoantibodies in a paraneoplastic context.

Authors:  Sean J Pittock; Vanda A Lennon
Journal:  Arch Neurol       Date:  2008-05
View more
  1 in total

1.  A Case of Late-Onset Neuromyelitis Optica Spectrum Disorder Associated With Cryptogenic Organizing Pneumonia.

Authors:  Seung Won Ra; Soyeoun Lim; Hee Jeong Cha; Sunyoung Kim
Journal:  Clin Med Insights Case Rep       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.